<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-11 17:00:28Medicine Health care Health Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Pegloticase Savient pharmaceuticals Gout Tophus Hyperuricemia Clinical trial |
Add to Reading List |
Microsoft Word - Savient press release re ACRdoc | Microsoft Word - Savient Press Release ACRdocDocID: 1rrcY - View Document |
| Microsoft Word - Savient press release re ACRdocDocID: 1reUR - View Document |
 | Microsoft Word - puricase-Phase I-ivpress release.docDocID: 1qOjy - View Document |
 | J Am Soc Nephrol 12: 1001–1009, 2001 Diabetes Insipidus in Uricase-Deficient Mice: A Model for Evaluating Therapy with Poly(Ethylene Glycol)-Modified Uricase SUSAN J. KELLY,* MARIELLE DELNOMDEDIEU,‡ MICHAEL I. OLIVEDocID: 1qiQw - View Document |
 | 5.0 ENDOCRINOLOGY 5.1 DIABETES MELLITUS Last Revised: OCT 2014 Last Reviewed: DEC 2014 Changes Include: Dysglycemia is now is a separate section of the waiver guide (ARWGDM Type 1DocID: 1q5is - View Document |